Erratum to "Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819]".

MLA

Piccirillo, Maria Carmela, et al. “Erratum to ‘Brief Report: Canadian Cancer Trials Group IND.227: A Phase II Randomized Study of Pembrolizumab in Patients with Advanced Malignant Pleural Mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819].’” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, Aug. 2024. EBSCOhost, https://doi.org/10.1016/j.jtho.2024.08.017.

APA

Piccirillo, M. C., Chu, Q., Bradbury, P., Tu, W., Coschi, C. H., Grosso, F., Florescu, M., Mencoboni, M., Goffin, J. R., Pagano, M., Ciardiello, F., Cecere, F. L., Vincent, M., Ferrara, R., Dawe, D. E., Hao, D., Lee, C. W., Morabito, A., Gridelli, C., … Laurie, S. A. (2024). Erratum to “Brief Report: Canadian Cancer Trials Group IND.227: A Phase II randomized study of pembrolizumab in patients with advanced malignant pleural mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819].” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer. https://doi.org/10.1016/j.jtho.2024.08.017

Chicago

Piccirillo, Maria Carmela, Quincy Chu, Penelope Bradbury, Wei Tu, Courtney H Coschi, Federica Grosso, Marie Florescu, et al. 2024. “Erratum to ‘Brief Report: Canadian Cancer Trials Group IND.227: A Phase II Randomized Study of Pembrolizumab in Patients with Advanced Malignant Pleural Mesothelioma (NCT02784171). [Journal of Thoracic Oncology Vol. 18 No. 6: 813-819].’” Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer, August. doi:10.1016/j.jtho.2024.08.017.